Sodium orthovanadate inhibits p53-mediated apoptosis (Cancer Research (2010) 70, (257-65) DOI: 10.1158/0008-5472.CAN-08-3771);Sodium orthovanadate inhibits p53-mediated apoptosis

Cancer Research

Volumn 70, Issue 1, 2010, Pages 257-265

  Morita, Akinori ^a   Yamamoto, Shinichi ^a   Wang, Bing ^b   Tanaka, Kaoru ^b   Suzuki, Norio ^c   Aoki, Shin ^d   Ito, Azusa ^a   Nanao, Tomohisa ^a   Ohya, Soichiro ^a   Yoshino, Minako ^a   Zhu, Jin ^d   Enomoto, Atsushi ^d   Matsumoto, Yoshihisa ^d   Funatsu, Osamu ^a   Hosoi, Yoshio ^d   Ikekita, Masahiko ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PIFITHRIN ALPHA; PIFITHRIN MU; PROTEIN BAK; PROTEIN BAX; PROTEIN BNIP3; PROTEIN P53; UNCLASSIFIED DRUG; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASSAY; BLOOD DISEASE; CELL LINE; CELL PROTECTION; CONFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GASTROINTESTINAL DISEASE; HEMATOPOIETIC SYNDROME; HUMAN; HUMAN CELL; LETHAL DOSE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RADIATION DOSE; RADIATION PROTECTION; STABLE TRANSFECTION; TEMPERATURE SENSITIVITY; TRANSCRIPTION INITIATION;

EID: 75149141328     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0036     Document Type: Erratum

References (37)

1. Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. pp. 117-34 Philadelphia: Lippincott Williams & Wilkins; 2006.
2. Dodd MJ. Managing the side effects of chemotherapy and radiation. San Francisco: UCSF Nursing Press; 2001.
3. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003;189:1-20.
4. Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-7.
5. Komarova EA, Kondratov RV, Wang KH, et al. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene 2004; 23:3265-71.
6. Strom E, Sathe S, Komarov PG, et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from ã radiation. Nat Chem Biol 2006;2:474-9.
7. Sugioka R, Shimizu S, Funatsu T, et al. BH4-domain peptide from Bcl-x(L) exerts anti-apoptotic activity in vivo. Oncogene 2003;22: 8432-40.
8. Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of tolllike receptor 5 has radioprotective activity in mouse and primate models. Science 2008;320:226-30.
9. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006;443:214-7.
10. Chernov MV, Stark GR. The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate. Oncogene 1997; 14:2503-10.
11. Meplan C, Mann K, Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem 1999;274:31663-70.
12. Morita A, Zhu J, Suzuki N, et al. Sodium orthovanadate suppresses DNA damage-induced caspase activation and apoptosis by inactivating p53. Cell Death Differ 2006;13:499-511.
13. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria-a potential role in apoptotic signaling. J Biol Chem 2000;275:16202-12.
14. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11:577-90.
15. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-4.
16. Leu JIJ, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004;6:443-50.
17. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 2007;26: 923-34.
18. Bonini P, Cicconi S, Cardinale A, et al. Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die. J Neurosci Res 2004;75:83-95.
19. Arima Y, Nitta M, Kuninaka S, et al. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 2005;280:19166-76.
20. Horton RM. In vitro recombination and mutagenesis of DNA. SOEing together tailor-made genes. In: White BA, editor. PCR cloning protocols. From molecular cloning to genetic engineering. New Jersey: Humana Press; 1997, p. 141-9.
21. Dumont P, Leu JIJ, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003;33:357-65.
22. Rocha S, Campbell KJ, Roche KC, Perkins ND. The p53-inhibitor pifithrin-α inhibits firefly luciferase activity in vivo and in vitro. BMC Mol Biol 2003;4.
23. Burdelya LG, Komarova EA, Hill JE, et al. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res 2006;66:9356-61.
24. Wei Q. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated p53 degradation in HeLa cells. J Biol Chem 2005;280:37790-97.
25. Jia LQ, Osada M, Ishioka C, et al. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinogen 1997;19: 243-53.
26. Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502-09.
27. Murai Y, Hayashi S, Takahashi H, Tsuneyama K, Takano Y. Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines. Pathol Res Pract 2005;201:109-15.
28. Bozulic L, Surucu B, Hynx D, Hemmings BA. PKBα/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 2008;30:203-13.
29. Enomoto A, Suzuki N, Kang Y, et al. Decreased c-Myc expression and its involvement in X-ray-induced apoptotic cell death of human T-cell leukaemia cell line MOLT-4. Int J Radiat Biol 2003; 79:589-600.
30. Jurgensmeier JM, Xie ZH, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A 1998;95:4997-5002.
31. Roucou X, Martinou JC. Conformational change of Bax: a question of life or death. Cell Death Differ 2001;8:875-7.
32. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999;144:891-901.
33. Lei M, Wang JF, Wang YM, et al. Study of the radio-protective effect of cuttlefish ink on hemopoietic injury. Asia Pac J Clin Nutr 2007;16: 239-43.
34. Kim SG, Nam SY, Kim CW. In vivo radioprotective effects of oltipraz in γ-irradiated mice. Biochem Pharmacol 1998;55:1585-90.
35. Mantena SK, Unnikrishnan MK, Joshi R, Radha V, Devi PU, Mukherjee T. In vivo radioprotection by 5-aminosalicylic acid. Mutat Res 2008; 650:63-79.
36. Baliga MS, Jagetia GC, Venkatesh P, Reddy R, Ulloor JN. Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br J Radiol 2004;77:1027-35.
37. Steele AJ, Prentice AG, Hoffbrand AV, et al. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 2008;112:3827-34.